These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26798171)

  • 1. Design, Development and Optimization of S (-) Atenolol Floating Sustained Release Matrix Tablets Using Surface Response Methodology.
    Gunjal PT; Shinde MB; Gharge VS; Pimple SV; Gurjar MK; Shah MN
    Indian J Pharm Sci; 2015; 77(5):563-72. PubMed ID: 26798171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
    Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and optimization of sustained release matrix tablet of Itopride HCl by response surface methodology and its evaluation of release kinetics.
    Bose A; Wong TW; Singh N
    Saudi Pharm J; 2013 Apr; 21(2):201-13. PubMed ID: 23960836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension.
    Maddiboyina B; Hanumanaik M; Nakkala RK; Jhawat V; Rawat P; Alam A; Foudah AI; Alrobaian MM; Shukla R; Singh S; Kesharwani P
    Heliyon; 2020 Nov; 6(11):e05459. PubMed ID: 33241144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride.
    Nigusse B; Gebre-Mariam T; Belete A
    PLoS One; 2021; 16(6):e0253391. PubMed ID: 34170952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol.
    Jagdale SC; Sali MS; Barhate AL; Kuchekar BS; Chabukswar AR
    PDA J Pharm Sci Technol; 2013; 67(3):214-28. PubMed ID: 23752749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
    Basak SC; Rahman J; Ramalingam M
    Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of floating matrix tablet of stavudine.
    Prajapati PH; Nakum VV; Patel CN
    Int J Pharm Investig; 2012 Apr; 2(2):83-9. PubMed ID: 23119237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug.
    Gharti K; Thapa P; Budhathoki U; Bhargava A
    J Young Pharm; 2012 Oct; 4(4):201-8. PubMed ID: 23493037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, preparation, and
    Patel M; Shelke S; Surti N; Panzade P; Al-Keridis LA; Upadhyay TK; Alshammari N; Saeed M
    Front Pharmacol; 2023; 14():1140351. PubMed ID: 37006995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and release mechanism of tectorigenin intragastric floating sustained-release tablets].
    Wang JF; Wang F; Zhao N; Yang CY; Wang GY; Wei Y; Zhang WY
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(2):298-302. PubMed ID: 28948734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in vitro analysis of floating matrix tablets of metronidazole using Brachystegia eurycoma gum.
    Ovenseri AC; Clifford O; Uwumagbe UM
    Pak J Pharm Sci; 2018 Jul; 31(4):1243-1249. PubMed ID: 30033407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
    Singh I; Saini V
    Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
    Srivastava AK; Wadhwa S; Ridhurkar D; Mishra B
    Drug Dev Ind Pharm; 2005 May; 31(4-5):367-74. PubMed ID: 16093202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, development and evaluation of clopidogrel bisulfate floating tablets.
    Rao KR; Lakshmi KR
    Int J Pharm Investig; 2014 Jan; 4(1):19-26. PubMed ID: 24678458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of gastroretentive floating tablets of an antihypertensive drug using hydrogenated cottonseed oil.
    Pawar HA; Gharat PR; Dhavale RV; Joshi PR; Rakshit PP
    ISRN Pharm; 2013 Dec; 2013():137238. PubMed ID: 24455312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of floating matrix tablets and evaluation of their gastric residence time.
    Baumgartner S; Kristl J; Vrecer F; Vodopivec P; Zorko B
    Int J Pharm; 2000 Feb; 195(1-2):125-35. PubMed ID: 10675690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of single and bilayered lamotrigine floating tablets.
    Lakshmi P; Sridhar M; Shruthi B
    Int J Pharm Investig; 2013 Jul; 3(3):157-62. PubMed ID: 24167788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori.
    Patel SS; Ray S; Thakur RS
    Acta Pol Pharm; 2006; 63(1):53-61. PubMed ID: 17515330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study.
    Owayez AS; Abd El-Ghany GM; Abu Hashim II
    Chem Pharm Bull (Tokyo); 2017; 65(6):545-557. PubMed ID: 28566647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.